NCT06088485

Brief Summary

The study was conducted in the age range of 18-45 December, who were diagnosed with Cystic fibrosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 5, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 12, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 18, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 22, 2024

Completed
25 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 16, 2024

Completed
Last Updated

November 14, 2023

Status Verified

November 1, 2023

Enrollment Period

5 months

First QC Date

October 12, 2023

Last Update Submit

November 13, 2023

Conditions

Cystic FibrosisPostural DefectPulmonary DiseasePhysical Inactivity

Outcome Measures

Primary Outcomes (1)

  • Functional Exercise Capacity

    Functional exercise capacity by incremental shuttle walk test in patients with adult Cystic Fibrosis

    1 day

Secondary Outcomes (1)

  • Posture

    1 day

Study Arms (2)

low bone mineral density

bone mineral density according to t and z score.

normal bone mineral density

bone mineral density according to t and z score.

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Patients referred by the department of chest diseases of Hacettepe University will be taken

You may qualify if:

  • Patients aged between 18-45 who were diagnosed with Cystic Fibrosis

You may not qualify if:

  • In the last year, patients;
  • who had a fracture in any part of the patient's body
  • who had undergone spine surgery
  • who had an orthopedic, neurological or metastatic history in addition to Cystic Fibrosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe University, Health Sciences Faculty

Ankara, 06100, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Cystic FibrosisLung DiseasesSedentary Behavior

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, DiseasesBehavior

Study Officials

  • Aynur Demirel

    Hacettepe University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Aynur Demirel, PhD

CONTACT

05545295057aynurdemirel629@hotmail.com

Aynur Demirel

CONTACT

05545295057aynurdemirel629@hotmail.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PT, PhD, Assoc. Prof.

Study Record Dates

First Submitted

October 12, 2023

First Posted

October 18, 2023

Study Start

September 5, 2023

Primary Completion

January 22, 2024

Study Completion

February 16, 2024

Last Updated

November 14, 2023

Record last verified: 2023-11

Locations

TU(1)